A testament to the growth-promoting prowess of GLI proteins in certain cancer types such as basal cell carcinoma and medulloblastoma is the continued reliance of cancerous cells resistant to SMO antagonists on GLI activity5. The gene discussed is GLI1; the disease is cancer.